Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Metolazone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Metolazone 2.5mg tablets
0202010V0AAANAN
|
Metolazone | Metolazone | Cardiovascular System | 2,388 |
|
Metolazone 5mg tablets
0202010V0AAAAAA
|
Metolazone | Metolazone | Cardiovascular System | 1,326 |
|
Metolazone 2.5mg/5ml oral liquid
0202010V0AAAKAK
|
Metolazone | Metolazone | Cardiovascular System | 2 |
|
Metolazone 1.25mg/5ml oral liquid
0202010V0AAAMAM
|
Metolazone | Metolazone | Cardiovascular System | No data available |
|
Metolazone 1mg/5ml oral liquid
0202010V0AAAFAF
|
Metolazone | Metolazone | Cardiovascular System | No data available |
|
Metolazone 500micrograms/5ml oral liquid
0202010V0AAAJAJ
|
Metolazone | Metolazone | Cardiovascular System | No data available |
|
Metolazone 5mg/5ml oral liquid
0202010V0AAAHAH
|
Metolazone | Metolazone | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.